Can-Fite BioPharma Ltd. (CANF)
NYSEAMERICAN: CANF · Real-Time Price · USD
2.182
-0.028 (-1.27%)
Oct 2, 2026, 4:00 PM EDT - Market closed
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of $6.5 million as of October 2, 2026. Its market cap has decreased by -57.98% in one year.
Market Cap
6.50M
Enterprise Value
-252.52K
1-Year Change
-57.98%
Ranking
Category
Stock Price
$2.18
ChartMarket Cap Chart
Since November 3, 2008, Can-Fite BioPharma's market cap has decreased from $18.49M to $6.50M, a decrease of -64.84%. That is a compound annual growth rate of -5.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 6.50M | -73.62% |
| Dec 31, 2025 | 24.64M | 58.34% |
| Dec 31, 2024 | 15.56M | 75.98% |
| Dec 31, 2023 | 8.84M | -54.56% |
| Dec 29, 2022 | 19.46M | -49.59% |
| Dec 30, 2021 | 38.60M | 34.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Exicure | 7.40M |
| Imunon | 7.29M |
| Skye Bioscience | 7.17M |
| Bolt Biotherapeutics | 6.95M |
| CollPlant Biotechnologies | 6.88M |
| Acurx Pharmaceuticals | 6.75M |
| Alzamend Neuro | 6.71M |
| Lunai Bioworks | 6.53M |